Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in $3.85 Million Public Offering of Innovus Pharmaceuticals, Inc.
Press Release – New York, NY – March 21, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw a unit of H.C. Wainwright as Exclusive Placement Agent in the public offering of common stock and Warrants of Innovus Pharmaceuticals, Inc. (“INNV.OTC).
Innovus is a specialty pharmaceutical company focused on OTC non –prescription drugs to improve men’s and women’s health. Innovus received approximately $3.85 million in gross proceeds from the sale of 25,666,669 shares common stock and an equal number of 1 and 5 year warrants sold at a price to the public of $.15 per share and $.15 exercise price of the warrants
The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia, Tom Rose and Associate Jay Yamamoto.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner LLP代表MoneyOnMobile，Inc.以500万美元的私人配售 - February 12, 2018
- Sichenzia Ross Ference Kesner LLP代表MoneyOnMobile，Inc.以7.6百万美元的私人配售 - February 8, 2018
- Sichenzia Ross Ference Kesner LLP代表Roth Capital Partners和布鲁克莱恩证券（Brookline Securities）共同出资550万美元在QBIO Med。 - February 1, 2018